Nova Zelândia - inglês - Ministry for Primary Industries

zoetis new zealand limited - vitamin e acetate; pyridoxine hydrochloride; vitamin b2 (riboflavin); thiamine hydrochloride; vitamin a; l-methionine; vitamin c (ascorbic acid); thioctic acid; calcium pantothenate; norethandrolone; magnesium phosphate tribasic; calcium phosphate dibasic; niacinamide; cholecalciferol - vitamin e acetate 2.95 g/kg; pyridoxine hydrochloride 0.6 g/kg; vitamin b2 (riboflavin) 2 g/kg; thiamine hydrochloride 4.4 g/kg; vitamin a 4.6 g/kg; l-methionine 14.8 g/kg; vitamin c (ascorbic acid) 59.1 g/kg; thioctic acid 2.95 g/kg; calcium pantothenate 4.4 g/kg; norethandrolone 14.8 g/kg; magnesium phosphate tribasic 146 g/kg; calcium phosphate dibasic 583.4 g/kg; niacinamide 14.8 g/kg; cholecalciferol 0.03 g/kg - endocrine agent (hormone)

Canadá - inglês - Health Canada

stanley pharmaceuticals, a division of vita health products inc. - vitamin b2 - tablet - 5mg - vitamin b2 5mg - vitamin b complex

Canadá - inglês - Health Canada

swiss herbal remedies ltd. - vitamin b2 - tablet - 10mg - vitamin b2 10mg - vitamin b complex

Estados Unidos - inglês - NLM (National Library of Medicine)

gm pharmaceuticals, inc - .beta.-carotene (unii: 01yae03m7j) (.beta.-carotene - unii:01yae03m7j), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol, dl- (unii: 7qwa1rio01) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), pyridoxine hydrochlo - .beta.-carotene 2500 [iu] - escavite® d multi-vitamin with iron and fluoride chewable tablets is a prescription drug product for the dietary management of the metabolic processes of caries prophylaxis, and provides supplementation of the diet with twelve essential vitamins, magnesium, zinc, copper and iron. escavite® d multi-vitamin with iron and fluoride chewable tablets provide 0.25 mg of fluoride in a chewable tablet form for children 4-6 years of age where the drinking water contains 0.3 through 0.6 ppm of fluoride. escavite® d multi-vitamin with iron and fluoride chewable tablets supply significant amounts of vitamins a, c, d, e, thiamine, riboflavin, niacin, vitamin b6, folate, vitamin b12, biotin, pantothenic acid, to supplement the diet, and to help assure that nutritional deficiencies of these vitamins will not develop. thus, in a single easy-to-use preparation, children obtain twelve essential vitamins and the important minerals, magnesium, zinc, copper, iron and fluoride. the american academy of pediatrics recommends that chi

Estados Unidos - inglês - NLM (National Library of Medicine)

mylan institutional llc - thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), dexpanthenol (unii: 1o6c93ri7z) (dexpanthenol - unii:1o6c93ri7z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z) - thiamine 100 mg in 1 ml - in disorders requiring parenteral administration of vitamins, i.e. pre- and post-operative treatment, when requirements are increased as in fever, severe burns, increased metabolism, pregnancy, gastrointestinal disorders interfering with intake or absorption of vitamins, prolonged or wasting diseases, alcoholism and where other deficiencies exist. sensitivity to the ingredients listed.

Estados Unidos - inglês - NLM (National Library of Medicine)

merit pharmaceutical - thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), dexpanthenol (unii: 1o6c93ri7z) (dexpanthenol - unii:1o6c93ri7z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4) - thiamine hydrochloride 100 mg in 1 ml - indications and usage:   in disorders requiring parenteral administration of vitamins, i.e. pre- and post-operative treatment, when requirements are increased as in fever, severe burns, increased metabolism, pregnancy, gastrointestinal disorders interfering with intake or absorption of vitamins, prolonged or wasting diseases, alcoholism and where other deficiencies exist. contraindications: sensitivity to the ingredients listed.

Estados Unidos - inglês - NLM (National Library of Medicine)

virtus pharmaceuticals - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), biotin (unii: 6so6u10h04) (biotin - un - ascorbic acid 25 mg - virt-c dha is an orally administered prescription dietary supplement and should be administered under the supervision of a licensed medical practitioner. vitamin c * 25 mg 42% thiamine mononitrate (b1 ) 2 mg 118% riboflavin (b2 ) 3 mg 150% niacin (b3 )* 1.8 mg 9% pyridoxine hcl (b6 ) 25 mg 1000% folic acid 1 mg 125% cyanocobalamin (b12 ) 12.5 mcg 156% biotin (b7 ) 300 mcg 100% d-calcium pantothenate (b5 ) 5 mg 50% ferrous fumarate (anhydrous) (equivalent to about 17.5 mg of elemental iron) 53.5 mg† polysaccharide iron complex (equivalent to about 17.5 mg of elemental iron) 38 mg† ‡194% magnesium (as magnesium sulfate) 5 mg 1% zinc (as zinc sulfate) 10 mg 67% copper (as copper sulfate) 2 mg 100% omega-3 fatty acids § 200 mg ¶   docosahexaenoic acid (dha) 156 mg ¶   eicosapentaenoic acid (epa) 39 mg ¶ other ingredients: lecithin, beeswax, soybean oil, caramel, capsule (gelatin, glycerin, water, and caramel). contains soy and fish oil.

Estados Unidos - inglês - NLM (National Library of Medicine)

hospira, inc. - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), retinol (unii: g2sh0xkk91) (retinol - unii:g2sh0xkk91), ergocalciferol (unii: vs041h42xc) (ergocalciferol - unii:vs041h42xc), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), de - ascorbic acid 80 mg in 5 ml - m.v.i. pediatric is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition. the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. m.v.i. pediatric is contraindicated in patients who have: - a history of known hypersensitivity to any of the vitamins or excipients in m.v.i. pediatric [see warnings and precautions (5.2), adverse reactions (6)] - an existing hypervitaminosis the safety and effectiveness of m.v.i. pediatric for the prevention of vitamin deficiency have been established in pediatric patients up to 11 years of age receiving parenteral nutrition. the safety and effectiveness of m.v.i. pediatric have not been established in pediatric patients older than 11 years of age. m.v.i. pediatric contains aluminum that may be toxic for premature neonates. aluminum levels should be monitored periodically during administration of m.v.i. pediatric to p

Estados Unidos - inglês - NLM (National Library of Medicine)

hospira, inc. - retinol (unii: g2sh0xkk91) (retinol - unii:g2sh0xkk91), ergocalciferol (unii: vs041h42xc) (ergocalciferol - unii:vs041h42xc), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464 - retinol 1 mg in 5 ml - m.v.i. adult™ is a combination of vitamins indicated for the prevention of vitamin deficiency in adults and pediatric patients aged 11 years and above receiving parenteral nutrition. the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. m.v.i. adult is contraindicated in patients who have: risk summary administration of the approved recommended dose of m.v.i. adult in parenteral nutrition is not expected to cause major birth defects, miscarriage, or adverse maternal or fetal outcomes. pregnant women should follow the u.s. recommended daily allowances for pregnancy because their vitamin requirements may exceed those of nonpregnant women. deficiency of essential vitamins may result in adverse pregnancy outcomes (see clinical considerations) . animal reproduction studies have not been conducted with m.v.i. adult administered by intravenous infusion. the estimated background risk of major birth defects and miscarriage for the indicated population

Estados Unidos - inglês - NLM (National Library of Medicine)

sandoz inc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii - ascorbic acid 80 mg in 4 ml - infuvite pediatric is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition. the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. infuvite pediatric is contraindicated in patients who have: infuvite pediatric has not been studied in pregnant women. pregnant women should follow the u.s. recommended daily allowances for pregnancy because their vitamin requirements may exceed those of non-pregnant women. animal reproduction studies have not been conducted with infuvite pediatric (multiple vitamins injection). infuvite pediatric has not been studied in nursing mothers. lactating women may have vitamin requirements that exceed those of non-lactating women. caution should be exercised when infuvite pediatric is administered to nursing mothers. infuvite pediatric is approved for the prevention of vitamin deficiency in pediatric patients up to 11 years